Table 2.
Sample | N | Clinician WAI Total Score1 | Patient WAI Total Score2 | Percent Days Abstinent | Percent Visits Attended3 |
---|---|---|---|---|---|
Total | 194 | 193.8 (26.3) | 213.0 (29.5) | 85.1 (19.8) | 70.9 (30.0) |
Male | 144 | 191.7 (25.8) | 215.4 (27.4) | 86.3 (19.2) | 71.9 (29.3) |
Female | 50 | 199.4 (27.3) | 206.4 (34.2) | 81.6 (21.3) | 68.1 (32.2) |
Naltrexone | 103 | 192.0 (25.7) | 215.4 (26.8) | 86.6 (17.5) | 70.4 (30.5) |
Placebo | 91 | 195.3 (26.9) | 210.9 (31.6) | 83.8 (21.6) | 71.4 (29.7) |
Doctor Only | 64 | 175.0 (24.7) | 203.4 (35.4) | 82.3 (21.1) | 80.5 (26.2) |
BRENDA | 67 | 198.7 (17.0) | 215.1 (28.9) | 85.3 (19.0) | 72.7 (28.5) |
CBT | 63 | 208.5 (25.0) | 219.7 (21.0) | 87.8 (19.1) | 59.4 (31.8) |
For Clinician WAI Total Score - Doctor Only < BRENDA < CBT (p < .0001)
For Patient WAI Total Score - Doctor Only < BRENDA = CBT (p < .01)
For Percent Visits Attended - Doctor Only = BRENDA > CBT (p < .001)